Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Part of paid clinical trials in San Jose, California.
- Sponsor
- University of Utah
- Study ID
- NCT05444582
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Contraception
Eligibility Criteria
- Sex
- FEMALE
- Age
- 16 Years - 35 Years
- Healthy Volunteers
- Not accepted
Interventions
- Levonorgestrel 52 MG Intrauterine System — DRUGEligible participants must be 16-35 years old, meet clinic eligibility for IUD placement, and having a LNG 52 mg IUD placed for either: Emergency Contraception (had unprotected intercourse in the last 5 days) OR Same-day start - \>7 days since the onset of last menstrual period and have no report of unprotected intercourse in the last 5 days.
Study Details
This is a prospective clinical research study to test the effectiveness of the Levonorgestrel (LNG) 52 mg Intrauterine Device (IUD) for emergency contraception (EC) and same-day start use that will enroll people receiving care at Planned Parenthood affiliates across the U.S. Our prior work demonstrated efficacy (shows that it works in an ideal setting) for the LNG 52 mg IUD for these uses and this study will test effectiveness (how well it works in the real world) in a larger, heterogenous population in a usual care setting where participants select their method and are not randomly assigned to it. The study population will include people initiating an LNG 52 mg IUD and meet inclusion and exclusion criteria at 8 Planned Parenthood affiliates nationwide. Planned Parenthood Federation of America was the first major healthcare organization to change its practice to incorporate the changes we are studying here. As such, all study participants will be offered the opportunity to choose the interventional IUD at the site they visit. The primary outcome is pregnancy status one month after LNG IUD placement by home urine pregnancy test or clinical record review. Participant follow up concludes one month after enrollment. The purpose of this study is to demonstrate reproducibility of earlier findings in a more heterogenous population. As such, IUD placement is not a study procedure but a component of clinical care. The study interventions only involve study participation and provision of data around the use of the levonorgestrel 52 mg IUD for EC or same day start.
Key Dates
- Start date
- Nov 7, 2022
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 1,404 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: 52 mg LNG IUD Same Day Start or ECWeek 1: Text daily for seven days. Report occurrences of the following in the last day: presence or absence of bleeding, spotting, pain, sexual intercourse, use of other methods of contraception, IUD expulsion or removal, and report any additional medical care received. Weeks 2 \& 3: Weekly text survey assessing on which days of the previous week participants experienced bleeding and spotting, sexual intercourse, use of other methods of contraception, IUD expulsion or removal, or experienced adverse events. Week 4 Survey: At 28 days, participants will be asked about pregnancy symptoms, concern about pregnancy, and the result of their urine pregnancy test including a prompt to upload a photo of the test.
Primary Outcome Measure
Number of pregnancies reported in participants at one month post insertion of IUD [ Time Frame: One Month ]
Central Contacts
- Corinne Sexsmith801-213-2522
- Sarah Elliott, MPH
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Planned Parenthood Mar Monte | San Jose | California | 95126 | Corinne Sexsmith |
| Planned Parenthood of the Rocky Mountains | Denver | Colorado | 80207 | Corinne Sexsmith |
| Planned Parenthood Illinoi | Chicago | Illinois | 60603 | Corinne Sexsmith |
| Planned Parenthood League of Massachusetts | Boston | Massachusetts | 02215 | Corinne Sexsmith |
| Planned Parenthood North Central States | Saint Paul | Minnesota | 55114 | - |
| Planned Parenthood Columbia Willamette | Portland | Oregon | 97212 | Corinne Sexsmith |
| Planned Parenthood Association of Utah | Salt Lake City | Utah | 84102 | Corinne Sexsmith |
| Planned Parenthood Great Northwest Hawaii, Alaska, Indiana, Kentucky | Seattle | Washington | 98122 | Corinne Sexsmith |
Find similar trials in San Jose, CA
Related Studies
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptPHASE3 · Not Yet Recruiting · Sebela Women's Health Inc. · Berkeley, California
- Etonogestrel Implant as Emergency ContraceptionPHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Endometrial Biopsy in Progestin Contraceptive UsersEARLY_PHASE1 · Recruiting · Oregon Health and Science University · Portland, Oregon
- Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive YearsRecruiting · Emory University · Boston, Massachusetts